Cell:29

Cell:29 is a biotechnology company specializing in stable cell line development, bioprocess optimization, and high-yield protein and antibody production for the biopharmaceutical industry. Combining advanced cell engineering with integrated R&D and GMP-ready solutions, they help accelerate, de-risk, and scale biologics development from discovery to manufacturing.